hepaCAM antibody
Principal name
hepaCAM antibody
Alternative names for hepaCAM antibody
Hepatocyte cell adhesion molecule
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of hepaCAM antibody
- Kit Component:
- - KN307662G1, Hepacam gRNA vector 1 in pCas-Guide vector
- KN307662G2, Hepacam gRNA vector 2 in pCas-Guide vector
- KN307662D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Yang, S., et al. World J Urol 28(4):473-478(2010)
Zhang, T., et al. Int. J. Oncol. 37(1):155-165(2010)
Davila, S., et al. Genes Immun. 11(3):232-238(2010)
He, Y., et al. BMC Cancer 10, 83 (2010)
Lee, L.H., et al. J. Cell. Biochem. 107(6):1129-1138(2009)

Human HT1080; WB Suggested Anti-HEPACAM Antibody Titration: 0.2-1 ug/ml. Positive Control: HT1080 cell lysate; HEPACAM antibody - N-terminal region (ARP55504_P050) in Human HT1080 cells using Western Blot

Western blot analysis of hepaCAM Antibody (C-term) Cat.-No AP52030PU-N in HepG2 cell line lysates (35ug/lane). This demonstrates the HEPACAM antibody detected the HEPACAM protein (arrow).
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP52030PU-N | hepaCAM (C-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP323693 | hepaCAM |
||||
| Recombinant protein of human hepatocyte cell adhesion molecule (HEPACAM) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||



